Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) Director Nitin Kaushal sold 5,995 shares of Viemed Healthcare stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total transaction of $51,437.10. Following the completion of the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at approximately $1,088,312.94. This trade represents a 4.51 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Nitin Kaushal also recently made the following trade(s):
- On Monday, November 11th, Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00.
Viemed Healthcare Stock Performance
NASDAQ:VMD traded up $0.01 on Tuesday, hitting $8.66. The company’s stock had a trading volume of 107,592 shares, compared to its average volume of 153,692. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $10.44. The firm has a market capitalization of $337.22 million, a P/E ratio of 32.04 and a beta of 1.43. The stock has a fifty day moving average of $8.51 and a two-hundred day moving average of $7.57. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.
Institutional Trading of Viemed Healthcare
A number of hedge funds have recently modified their holdings of VMD. National Bank of Canada FI increased its position in Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after buying an additional 1,596 shares during the period. Evernest Financial Advisors LLC bought a new position in Viemed Healthcare in the second quarter valued at approximately $66,000. Perkins Coie Trust Co acquired a new position in shares of Viemed Healthcare during the 3rd quarter worth $73,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Viemed Healthcare during the 1st quarter worth $97,000. Finally, PDT Partners LLC bought a new stake in shares of Viemed Healthcare during the 3rd quarter worth $78,000. Institutional investors and hedge funds own 74.24% of the company’s stock.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
- Five stocks we like better than Viemed Healthcare
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Election Stocks: How Elections Affect the Stock Market
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Find Undervalued Stocks
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.